Home LiteratureArticle Details
PMID: 9823898 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

The murine gene p27Kip1 is haplo-insufficient for tumour suppression.

Nature ·Vol. 396 ·No. 6707 ·1998-11-12 ·Pages 177-80

Fero ML, Randel E, Gurley KE, Roberts JM, Kemp CJ

Abstract

p27Kip is a candidate human tumour-suppressor protein, because it is able to inhibit cyclin-dependent kinases and block cell proliferation. Abnormally low levels of the p27 protein are frequently found in human carcinomas, and these low levels correlate directly with both histological aggressiveness and patient mortality. However, it has not been possible to establish a causal link between p27 and tumour suppression, because only rare instances of homozygous inactivating mutations of the p27 gene have been found in human tumours. Thus, p27Kip1 does not fulfil Knudson's 'two-mutation' criterion for a tumour-suppressor gene. Here we show that both p27 nullizygous and p27 heterozygous mice are predisposed to tumours in multiple tissues when challenged with gamma-irradiation or a chemical carcinogen. Therefore p27 is a multiple-tissue tumour suppressor in mice. Molecular analyses of tumours in p27 heterozygous mice show that the remaining wild-type allele is neither mutated nor silenced. Hence, p27 is haplo-insufficient for tumour suppression. The assumption that null mutations in tumour-suppressor genes are recessive excludes those genes that exhibit haplo-insufficiency.

MeSH Terms
Animals Cell Cycle Proteins Cyclin-Dependent Kinase Inhibitor p27 Ethylnitrosourea Female Gamma Rays Genes, Tumor Suppressor Haplotypes Heterozygote Male Mice Mice, Inbred C57BL Microtubule-Associated Proteins/genetics Neoplasms, Experimental/genetics Tumor Suppressor Proteins
Chemicals
Cdkn1b protein, mouse Cell Cycle Proteins Microtubule-Associated Proteins Tumor Suppressor Proteins Cyclin-Dependent Kinase Inhibitor p27 Ethylnitrosourea
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Fero M L
Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA.
Randel E
Gurley K E
Roberts J M
Kemp C J
References (30)
30 references, click to expand
  1. Transgenic mouse model for studying the transcriptional activity of the p53 protein: age- and tissue-dependent changes in radiation-induced activation during embryogenesis.
    EMBO J. 1997 Mar 17;16(6):1381-90 PMID: 9135153
  2. Mutation and cancer: statistical study of retinoblastoma.
    Proc Natl Acad Sci U S A. 1971 Apr;68(4):820-3 PMID: 5279523
  3. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.
    Genes Dev. 1994 Jan;8(1):9-22 PMID: 8288131
  4. Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer.
    Cancer Res. 1997 Aug 15;57(16):3381-5 PMID: 9270000
  5. Thymocyte apoptosis induced by p53-dependent and independent pathways.
    Nature. 1993 Apr 29;362(6423):849-52 PMID: 8479523
  6. Mutational analysis of the candidate tumor suppressor genes TEL and KIP1 in childhood acute lymphoblastic leukemia.
    Cancer Res. 1996 Mar 15;56(6):1413-7 PMID: 8640833
  7. Role of the INK4a locus in tumor suppression and cell mortality.
    Cell. 1996 Apr 5;85(1):27-37 PMID: 8620534
  8. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas.
    Nat Med. 1997 Feb;3(2):231-4 PMID: 9018245
  9. Frequent loss of heterozygosity in region of the KIP1 locus in non-small cell lung cancer: evidence for a new tumor suppressor gene on the short arm of chromosome 12.
    Cancer Res. 1996 Feb 15;56(4):738-40 PMID: 8631006
  10. Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation.
    Cell. 1994 Nov 4;79(3):487-96 PMID: 7954814
  11. Heterozygous Rb-1 delta 20/+mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance.
    Oncogene. 1994 Apr;9(4):1021-7 PMID: 8134105
  12. Transforming growth factor-beta1 is a new form of tumor suppressor with true haploid insufficiency.
    Nat Med. 1998 Jul;4(7):802-7 PMID: 9662371
  13. Alterations of the p27KIP1 gene in non-Hodgkin's lymphomas and adult T-cell leukemia/lymphoma.
    Blood. 1995 Sep 1;86(5):1924-30 PMID: 7655021
  14. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients.
    Nat Med. 1997 Feb;3(2):222-5 PMID: 9018243
  15. Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin.
    Nature. 1994 Dec 8;372(6506):570-3 PMID: 7990932
  16. Homozygosity of chromosome 13 in retinoblastoma.
    N Engl J Med. 1984 Mar 1;310(9):550-3 PMID: 6694706
  17. Reduced expression of cyclin-dependent kinase inhibitor p27Kip1 is associated with advanced stage and invasiveness of gastric carcinomas.
    Jpn J Cancer Res. 1997 Jul;88(7):625-9 PMID: 9310133
  18. Spontaneous and ionizing radiation-induced chromosomal abnormalities in p53-deficient mice.
    Cancer Res. 1995 Sep 1;55(17):3883-9 PMID: 7641208
  19. Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle.
    Science. 1996 May 10;272(5263):877-80 PMID: 8629023
  20. Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice.
    Nat Genet. 1993 Nov;5(3):225-9 PMID: 8275085
  21. p27/Kip1 mutation found in breast cancer.
    Cancer Res. 1996 May 15;56(10):2400-4 PMID: 8625318
  22. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice.
    Cell. 1996 May 31;85(5):733-44 PMID: 8646781
  23. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas.
    Science. 1989 Apr 14;244(4901):217-21 PMID: 2649981
  24. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals.
    Cell. 1994 Jul 15;78(1):59-66 PMID: 8033212
  25. Low p27 expression predicts poor disease-free survival in patients with prostate cancer.
    J Urol. 1998 Mar;159(3):941-5 PMID: 9474188
  26. Effects of an Rb mutation in the mouse.
    Nature. 1992 Sep 24;359(6393):295-300 PMID: 1406933
  27. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies.
    Cancer Res. 1995 Jun 1;55(11):2266-9 PMID: 7757974
  28. Molecular analysis of cyclin-dependent kinase inhibitors in human leukemias.
    Leukemia. 1997 Oct;11(10):1696-9 PMID: 9324291
  29. A cell cycle regulator potentially involved in genesis of many tumor types.
    Science. 1994 Apr 15;264(5157):436-40 PMID: 8153634
  30. Assignment of the human p27Kip1 gene to 12p13 and its analysis in leukemias.
    Cancer Res. 1995 Mar 15;55(6):1206-10 PMID: 7882309
Article Info
Journal
Nature
Abbr.
Nature
ISSN
0028-0836
Published
1998-11-12
Pages
177-80
Language
English
Region
England
NLM ID
0410462
PMCID
PMC5395202
Subset
IM
Grants
NCI NIH HHS · K08 CA071464 · United States
NCI NIH HHS · R01 CA118043 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com